All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @saymaa_91 on TikTok · 8s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @saymaa_91's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Come, come, come, come, come!

@saymaa_91's 10-kilo Wegovy claim, fact-checked

🇨🇭 Influleleuse 🇨🇭

TikTok creator

10.9K viewsWatch on TikTok

Quick answer

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics hormones controlling blood sugar and appetite. Clinical trials show average weight loss of 14.9% over 68 weeks at the 2.4mg maintenance dose, though individual results vary significantly.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @saymaa_91's 10-kilo Wegovy claim, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@saymaa_91's 10-kilo Wegovy claim, fact-checked" from 🇨🇭 Influleleuse 🇨🇭. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics hormones controlling blood sugar and appetite.

The reason this review is not generic is the source wording and the canonical claim label "glp1 10 kilos en moins wegovy suisse tiktoksuisse perte." In this clip, the useful excerpt is: "Come, come, come, come, come!" That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

74% of STEP 1 participants experienced gastrointestinal side effects including nausea, vomiting, and diarrhea
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics hormones controlling blood sugar and appetite.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics hormones controlling blood sugar and appetite. Clinical trials show average weight loss of 14.9% over 68 weeks at the 2.4mg maintenance dose, though individual results vary significantly.
  • Wegovy (semaglutide) produced 14.9% average weight loss in the 68-week STEP 1 trial, making 10-kilo losses plausible depending on starting weight
  • 74% of STEP 1 participants experienced gastrointestinal side effects including nausea, vomiting, and diarrhea

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Wegovy (semaglutide) produced 14.9% average weight loss in the 68-week STEP 1 trial, making 10-kilo losses plausible depending on starting weight
  • 74% of STEP 1 participants experienced gastrointestinal side effects including nausea, vomiting, and diarrhea
  • Treatment requires 16-20 week dose escalation starting at 0.25mg weekly, increasing gradually to 2.4mg maintenance dose
  • Weight regain occurs when treatment stops, with patients regaining most lost weight within a year according to follow-up studies
  • Wegovy costs approximately $1,300 monthly in the US and requires ongoing medical supervision in most countries including Switzerland
  • The medication is approved for people with BMI ≥30 or BMI ≥27 with weight-related health complications, not general weight management
  • Individual results vary significantly, and the drug doesn't work equally well for everyone despite clinical trial averages

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

Swiss influencer @saymaa_91 posted a TikTok claiming she lost 10 kilos (22 pounds) on Wegovy, a semaglutide injection approved for weight management. The video has racked up nearly 11,000 views, but provides zero context about timeframe, side effects, or medical supervision.

What does this video actually claim?

The creator states she lost 10 kilos using Wegovy, hashtagging it as a weight loss success story from Switzerland. That's about it. No mention of how long this took, what dose she used, or whether she experienced any side effects.

The lack of detail is telling. Real weight loss with semaglutide doesn't happen overnight, and the medication comes with a substantial side effect profile that most users can't ignore. Her presentation makes it sound almost effortless.

The video essentially functions as a before-and-after testimonial without the medical context that would help viewers understand what Wegovy actually involves.

Is a 10-kilo loss realistic on Wegovy?

Yes, but it depends entirely on her starting weight and treatment duration. The STEP 1 trial (Wilding et al., NEJM, 2021) found participants lost an average of 14.9% of their body weight after 68 weeks on 2.4mg semaglutide.

If @saymaa_91 started at 80 kilos, a 10-kilo loss would represent 12.5% weight reduction, which falls within the expected range. But if she weighed 60 kilos initially, that same 10-kilo loss would be 16.7%, which is above average.

The STEP trials showed most weight loss occurred in the first 20 weeks, plateauing afterward. Without knowing her timeline, it's impossible to verify if her results align with clinical data.

What's missing from this success story?

The video completely ignores Wegovy's side effect profile, which affects nearly everyone who takes it. In STEP 1, 74% of participants experienced gastrointestinal side effects including nausea, vomiting, and diarrhea.

She also doesn't mention the medication's cost, which runs about $1,300 monthly in the US (Swiss pricing varies). Most people can't just casually try Wegovy like she implies.

The biggest omission is medical supervision. Wegovy requires careful dose escalation over 16-20 weeks, starting at 0.25mg weekly and increasing gradually to prevent severe nausea. You can't just start taking it and expect smooth sailing.

What should you actually know about Wegovy?

Semaglutide works by mimicking GLP-1, a hormone that slows digestion and signals fullness to your brain. It's not a quick fix or lifestyle hack, it's a prescription medication for people with obesity or overweight with complications.

The weight loss is real, but it requires ongoing treatment. STEP 1 showed that people who stopped semaglutide regained most of the weight within a year. You're essentially committing to long-term therapy.

Swiss regulations require medical oversight for Wegovy prescriptions, so @saymaa_91 presumably had proper monitoring. But her casual presentation doesn't reflect the medical complexity involved in safe semaglutide treatment.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

🇨🇭 Influleleuse 🇨🇭 · TikTok creator

10.9K views on this video

10 kilos en moins 👑#wegovy #suisse #tiktoksuisse🇨🇭 #pertedepoids

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about wegovy (semaglutide) produced 14.9% average weight loss in the 68-week?

Wegovy (semaglutide) produced 14.9% average weight loss in the 68-week STEP 1 trial, making 10-kilo losses plausible depending on starting weight

What does the video say about 74% of step 1 participants experienced gastrointestinal side effects including?

74% of STEP 1 participants experienced gastrointestinal side effects including nausea, vomiting, and diarrhea

What does the video say about treatment requires 16-20 week dose escalation starting at 0.25mg weekly,?

Treatment requires 16-20 week dose escalation starting at 0.25mg weekly, increasing gradually to 2.4mg maintenance dose

What does the video say about weight regain occurs?

Weight regain occurs when treatment stops, with patients regaining most lost weight within a year according to follow-up studies

What does the video say about wegovy costs approximately $1,300 monthly in the us?

Wegovy costs approximately $1,300 monthly in the US and requires ongoing medical supervision in most countries including Switzerland

What does the video say about the medication?

The medication is approved for people with BMI ≥30 or BMI ≥27 with weight-related health complications, not general weight management

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by 🇨🇭 Influleleuse 🇨🇭, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.